The scientific goal of the Cancer Control Program is to foster population-based research that will lead to a reduction in cancer morbidity and mortality in South Carolina while providing scientific evidence and novel cancer control interventions that can be applied beyond the state’s borders. The Cancer Control Program investigators have made substantive progress toward this goal, primarily through focused research efforts in two major themes – generating novel insights and approaches to tobacco control and addressing cancer health disparities.
Led by Program Leader Chanita Hughes-Halbert, PhD,
the Cancer Control Program Members work collaboratively to
1) conduct and link research that identifies behavioral risk factors predisposing individuals to cancer development, and
2) translate these findings into cost-effective, sustainable interventions to modify risk factors. Further, the Cancer Control Program members are working with government and community leaders to disseminate these evidence-based strategies to impact the cancer burden in South Carolina.
Featured Research Project
Innovative Interventions Show Promise for Adolescent and Adult Smokers: The HCC tobacco control group continues to be at the forefront of treatment outcome research among both adolescents and adults. The vast majority of smokers initiate smoking during adolescence, creating a national imperative to develop effective prevention and cessation strategies to arrest the onset and development of nicotine addiction. (MORE)
The Evidence Against the Health Effects of Tobacco Mount and CVS Responds
"The landmark 50th Anniversary of the Surgeon General's Report was released on January 17, 2014. The Report continued to show that smoking causes cancer, heart disease, pulmonary disease, and several other chronic health conditions. The Report was the first to also show that continued smoking by cancer patients causes increased overall mortality and mortality from cancer.
CVS Caremark has now announced that it will no longer sell tobacco products starting October 1. "This is a landmark event by a major retailer to take a firm stand against the health effects of tobacco," says Dr. Graham Warren M.D., Ph.D., Vice Chairman for Research in Radiation Oncology and Chair of the Tobacco Oversight Committee at the Medical University of South Carolina. "For years, tobacco sales have represented a significant source of revenue for pharmacies, yet have contradicted the purpose of promoting health. I am extremely happy to see the active efforts by CVS to address what is one of the largest preventable causes of disease and death worldwide."
"The healthcare benefits associated with this decision are profound," says Dr. Michael Cummings, Ph.D. M.P.H., Professor of Psychiatry and Health Behavior at MUSC. "This will limit access to tobacco products thereby preventing addiction and reducing the risk of developing chronic diseases associated with tobacco use. The economic benefits of this decision by CVS far outweigh the profits from tobacco sales."
"The decision by CVS to stop tobacco sales is an active move to make a difference," says Dr. Anthony Alberg, Ph.D. M.P.H., Professor and Endowed Blatt Ness Endowed Chair of Oncology. "This is a strong leadership position CVS has taken nationwide and now sets the standard for other healthcare retailers to follow to significantly improve the health of the nation."
The CNN news release can be found here.
Featured Program News
Q&A with Marvella Ford, a two-time breast cancer survivor and MUSC cancer researcher
South Carolina Tobacco Research Group (SC TRIG)